Suppliers / Chongqing Land Tower Pharmaceutical

Chongqing Land Tower Pharmaceutical

Updated 9 July 2026

Chongqing Land Tower Pharmaceutical is an API manufacturer. It holds 2 active US drug master files across a filed portfolio of 3 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Clindamycin SFDA (Saudi Arabia) 1
Methylnaltrexone US FDA 1
Naltrexone US FDA 1

Also appears on these molecule pages

Naltrexone API Clindamycin API

Comparing suppliers?

Choose your molecules and target markets. Chongqing Land Tower Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability